Whitehawk Therapeutics, Inc. (WHWK) Operating cash flow 2016–2025
Whitehawk Therapeutics, Inc. (WHWK) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$97.4MFY2025 · since FY2016: -$24,517 → -$97.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$97.4M | -63.6% |
| FY2024 | -$59.5M | +0.2% |
| FY2023 | -$59.7M | -20.2% |
| FY2022 | -$49.6M | -121.4% |
| FY2021 | -$22.4M | -76.5% |
| FY2020 | -$12.7M | +46.8% |
| FY2019 | -$23.9M | -310.7% |
| FY2018 | -$5.8M | +69.2% |
| FY2017 | -$18.9M | -76922.2% |
| FY2016 | -$24,517 | — |
Source: SEC XBRL filings · For reference only · Not investment advice